Chi Lin
Taiwan Adventist Hospital · Kaohsiung Medical University · University of Nebraska
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Chi Lin as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 00:38 UTC. Open this list on ClinicalTrials.gov
- N/ANCT07310576 · Health Diet Education on Nutrition Literacy and BehaviorEn-Chi Chiu · completed · Nutrition Status · principal investigator
- N/ANCT06371365 · Adverse Events for Free Flap Surgery in Head and Neck CancerKaohsiung Medical University · completed · Surgical Flaps, Flap Failure Risk Factors, Hematoma Risk Factors · principal investigator
- N/ANCT06020872 · My Meal Plate - Promoting the Health Literacy of PatientsEn-Chi Chiu · completed · Nutrition, Healthy · principal investigator
- Ph2NCT05254327 · Trial of the Efficacy and Safety of Short and Long Course Radiation Therapy With/Without BMX-001University of Nebraska · recruiting · Rectal Cancer · principal investigator
- Ph1NCT03810742 · Nanoliposomal Irinotecan (Nal-IRI, ONIVYDE®) in Combination With TAS-102 (LONSURF®) in Refractory Solid TumorsPharmaEngine · completed · Refractory Solid Tumors · principal investigator
- N/ANCT03490591 · Robot-assisted Hand Rehabilitation for Children With Cerebral Palsy: a Pilot StudyTaipei Medical University Shuang Ho Hospital · completed · Cerebral Palsy · study chair
- N/ANCT03392493 · Robot-assisted Hand Rehabilitation for Patients With StrokeTaipei Medical University Shuang Ho Hospital · completed · Stroke · study chair
- Ph1/Ph2NCT03386500 · Safety Study of BMX-001 (Radio-protector) in Patients With Newly Diagnosed Anal CancerUniversity of Nebraska · active not recruiting · Anal Cancer, Squamous Cell Carcinoma, Radiation Exposure · principal investigator
- Ph1NCT03256331 · Evaluate the Safety of BEL-X-HG in Advanced Cancer PatientsBelx Bio-Pharmaceutical (Taiwan) Corporation · terminated · Advanced Solid Tumors · principal investigator
- Ph2NCT03073785 · Hypofractionated Stereotactic Body Radiation & Fluorouracil or Capecitabine for Locally Advanced Pancreatic CancerUniversity of Nebraska · active not recruiting · Pancreatic Adenocarcinoma, Recurrent Pancreatic Carcinoma, Stage I Pancreatic Cancer AJCC v6 and v7 · principal investigator
- Ph2NCT02278978 · BIBF1120 in Patients With Advanced FGFR3 Mutated,Overexpressed,or Wild Type Urothelial CarcinomaNational Taiwan University Hospital · unknown · Urothelial Carcinoma · principal investigator
- Ph1NCT02151357 · Safety, Tolerability and Pharmacokinetics of DCBCI0901 in Patients With Advanced Solid TumorStandard Chem. & Pharm. Co., Ltd. · terminated · Cancer · principal investigator
- Ph2NCT01959672 · Chemotherapy, Stereotactic Body Radiation Therapy & Nelfinavir Mesylate in Locally Advanced Pancreatic CancerUniversity of Nebraska · completed · Pancreatic Adenocarcinoma, Resectable Pancreatic Carcinoma, Stage I Pancreatic Cancer · principal investigator
- Ph1NCT01800630 · Phase1 Study of Gemcitabine HCl Oral Formulation(D07001-F4) in Patients With Advanced Solid Malignancies and Malignant LymphomasInnoPharmax Inc. · completed · Advanced Solid Malignancies, Malignant Lymphomas · principal investigator
- Early Ph1NCT01678690 · An Exploratory Study of Gemcitabine Hydrochloride Oral Formulation (D07001-F4) in Subjects With Malignant TumorsInnoPharmax Inc. · completed · Malignant Tumors · principal investigator
- Ph1NCT01068327 · Stereotactic Radiation, Nelfinavir Mesylate & Neoadjuvant Chemotherapy in Locally Advanced Pancreatic CancerUniversity of Nebraska · completed · Adenocarcinoma of the Pancreas, Stage III Pancreatic Cancer · principal investigator
- N/ANCT00607828 · Stereotactic Radiation Therapy in Treating Patients With Advanced Liver CancerUniversity of Nebraska · completed · Liver Cancer · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 00:38 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 61 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
- Use of radioprotector in rectal cancerR01CA255618 · NCI · UNIVERSITY OF NEBRASKA MEDICAL CENTER · fiscal years 2022 to 2026 · $603,952 awarded in 2026Same name and institution; not confirmed by an ID
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- Buffett Cancer Center Support GrantP30CA036727 · NCI · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI Joann B. Sweasy · fiscal years 1985 to 2026
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 00:38 UTC. The ranking covers the 200 most relevant of 1610 PubMed records, and a shared surname and initials can bring in a namesake. All 1610 on PubMed
- 983 citationsRCR 35.4
- 802 citationsRCR 41.8
- Tocilizumab in systemic sclerosis: a randomised, double-blind, placebo-controlled, phase 3 trial.Lancet Respir Med · 2020566 citationsRCR 30.9
- 309 citationsRCR 23.8
- Tislelizumab Versus Chemotherapy as Second-Line Treatment for Advanced or Metastatic Esophageal Squamous Cell Carcinoma (RATIONALE-302): A Randomized Phase III Study.J Clin Oncol · 2022291 citationsRCR 18.2
- Cabozantinib for radioiodine-refractory differentiated thyroid cancer (COSMIC-311): a randomised, double-blind, placebo-controlled, phase 3 trial.Lancet Oncol · 2021212 citationsRCR 11.8
- 178 citationsRCR 5.8
- 158 citationsRCR 15.1
- Tocilizumab Prevents Progression of Early Systemic Sclerosis-Associated Interstitial Lung Disease.Arthritis Rheumatol · 2021151 citationsRCR 10.7
- Opioid analgesia for acute low back pain and neck pain (the OPAL trial): a randomised placebo-controlled trial.Lancet · 2023128 citationsRCR 22.7